Abcellera Biologics Inc (ABCL)

05:41 AM

What drives AbCellera Biologics Inc. stock priceExceptional ROI - Autocar Professional

05:41 AM

05:12 AM

AbCellera Biologics Inc. Stock Analysis and ForecastExplosive portfolio gains - Autocar Professional

05:12 AM

01:40 AM

AbCellera: Just Another Biotech Stock (NASDAQ:ABCL) - Seeking Alpha

01:40 AM

12:23 PM

Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot - MSN

12:23 PM

07:53 AM

Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? - MSN

07:53 AM

Jul 22, 2025

What analysts say about AbCellera Biologics Inc. stockBreakthrough financial growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is AbCellera Biologics Inc. a good long term investmentExplosive capital gains - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

ABCL.O Surges 15.5% Intraday: A Deep Dive Into the Drivers Behind the Sharp Move - AInvest

Jul 21, 2025

Jul 21, 2025

ABCL Stock Surge: Opportunity or Caution? - StocksToTrade

Jul 21, 2025

Jul 21, 2025

AbCellera Biologics Stock (ABCL) Opinions on Recent Price Surge - Quiver Quantitative

Jul 21, 2025

Jul 21, 2025

Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday - Benzinga

Jul 21, 2025

Jul 21, 2025

AbCellera Biologics (ABCL) Surges 18.75% Intraday: What’s Fueling This Biotech Breakout? - AInvest

Jul 21, 2025

Jul 18, 2025

AbCellera Bets Big On AI Antibody Discovery And Partnerships - Finimize

Jul 18, 2025

Jul 18, 2025

Abcellera Biologics stock hits 52-week high at $4.46 - Investing.com Australia

Jul 18, 2025

Jul 14, 2025

AbCellera Biologics' Mysterious 8.7% Spike: What's Driving the Rally? - AInvest

Jul 14, 2025

Jul 09, 2025

Leerink Partners Initiates Coverage on AbCellera Biologics with "Outperform" Rating and $5.00 Price Target - AInvest

Jul 09, 2025

Jul 07, 2025

Abcellera Biologics stock hits 52-week high at 4.09 USD By Investing.com - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

AbCellera's Strategic Pivot to Internal Pipelines Fuels Growth Potential in Antibody Therapies - AInvest

Jul 07, 2025

Jul 07, 2025

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire

Jul 07, 2025

Jul 07, 2025

Leerink Partners Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $5 - 富途牛牛

Jul 07, 2025

Jul 07, 2025

Abcellera Biologics stock hits 52-week high at 4.09 USD - Investing.com

Jul 07, 2025

Jul 07, 2025

AbCellera Biologics' 6% Surge: A Technical & Order-Flow Deep Dive - AInvest

Jul 07, 2025

Jul 07, 2025

Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating - MSN

Jul 07, 2025

Jul 07, 2025

Leerink Partners assumes coverage on AbCellera stock with Outperform rating - Investing.com

Jul 07, 2025

Jul 02, 2025

AbCellera Biologics' Mysterious 5.7% Spike: A Technical Deep Dive - AInvest

Jul 02, 2025

Jun 30, 2025

AbCellera Biologics: Fueling Growth Through Strategic Partnerships and R&D Reinvention - AInvest

Jun 30, 2025

Jun 25, 2025

AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology - Insider Monkey

Jun 25, 2025

Jun 25, 2025

AbCellera Biologics Soars 11.41% on Partnerships, Innovation - AInvest

Jun 25, 2025

Jun 24, 2025

Why Did AbCellera Biologics Jump 12%? Unraveling the Mysterious Spike - AInvest

Jun 24, 2025

Jun 18, 2025

AbCellera Biologics' 10.9% Surge Explained: Technical Momentum or Hidden Drivers? - AInvest

Jun 18, 2025

Jun 13, 2025

AbCellera shareholders approve board election and auditor - Investing.com Australia

Jun 13, 2025

Jun 13, 2025

AbCellera shareholders approve board election and auditor By Investing.com - Investing.com Nigeria

Jun 13, 2025

Jun 13, 2025

AbCellera Biologics Holds Annual Shareholder Meeting - TipRanks

Jun 13, 2025

Jun 13, 2025

AbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash Burn (ABCL) - Seeking Alpha

Jun 13, 2025